Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer
Nicholas Hardcastle, Olivia Cook, Xenia Ray, Alisha Moore, Kevin L Moore, David Pryor, Alana Rossi, Farshad Foroudi, Tomas Kron, Shankar Siva
RADIATION ONCOLOGY | BMC | Published : 2021
INTRODUCTION: Quality assurance (QA) of treatment plans in clinical trials improves protocol compliance and patient outcomes. Retrospective use of knowledge-based-planning (KBP) in clinical trials has demonstrated improved treatment plan quality and consistency. We report the results of prospective use of KBP for real-time QA of treatment plan quality in the TROG 15.03 FASTRACK II trial, which evaluates efficacy of stereotactic ablative body radiotherapy (SABR) for kidney cancer. METHODS: A KBP model was generated based on single institution data. For each patient in the KBP phase (open to the last 31 patients in the trial), the treating centre submitted treatment plans 7 days prior to treat..View full abstract
This work was funded by a Collaborative Research Grant from Varian Medical Systems.